Skip to content
The Nexus
DossierENTITY

Cosentyx

Coverage of Cosentyx in the Nexus archive.

Earliest in view: Jul 2 · 23:54 UTCMost recent: Jul 2 · 23:54 UTC
Co-mentioned in this coverage
Judge Daniel Domenicoperson1Amgenorganization1Enbreltopic1Colorado Prescription Drug Affordability Boardorganization1Colorado Consumer Health Initiativeorganization1Adam Foxperson1Colorado Division of Insuranceorganization1
Recent coverage
  • HEALTHJul 2 · 23:54 UTCKMGH DENVER7
    Judge suspends Colorado's price cap on prescription drug Embrel while lawsuit plays out

    A Colorado judge suspended the state's price cap on the arthritis drug Enbrel, ruling it interferes with federal patent law. The cap, set at $31,000 annually, was blocked ahead of its 2027 implementation. Colorado's Prescription Drug Affordability Board, the first state entity to price-cap a drug, now faces legal uncertainty as Amgen challenges the policy.